Advances in immunotherapy for triple-negative breast cancer

2023277 citationsReviewgold Open Access

Authors

Yang Liu · China Medical University

Yueting Hu · China Medical University

Jinqi Xue · China Medical University

Jingying Li · China Medical University

Yi Jiang · China Medical University

Jiawen Bu · China Medical University

Zhenyong Zhang ·

Abstract

This review provides insights into the approaches used to overcome drug resistance in immunotherapy, and explores the directions of immunotherapy development in the treatment of TNBC.

Topics & Keywords

Immunotherapy and Immune Responses Cancer Immunotherapy and Biomarkers Nanoplatforms for cancer theranostics

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Molecular Cancer

Volume 22, Issue 1, pp. 145-145

DOI: 10.1186/s12943-023-01850-7

Field-Weighted Citation Impact: 45.39